Zoryve Foam Side Effects
Generic name: roflumilast topical
Medically reviewed by Drugs.com. Last updated on Nov 19, 2024.
Note: This document provides detailed information about Zoryve Foam.
Applies to roflumilast topical: topical application cream Side Effects associated with roflumilast topical. Some dosage forms listed on this page may not apply specifically to the brand name Zoryve Foam.
Applies to roflumilast topical: topical application cream.
Precautions
It is very important that your doctor check your progress at regular visits to make sure this medicine is working properly and to check for any unwanted effects.
If your condition does not improve or if it becomes worse, check with your doctor.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Serious side effects of Zoryve Foam
Along with its needed effects, roflumilast topical (the active ingredient contained in Zoryve Foam) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking roflumilast topical:
Less common side effects
- bladder pain
- bloody or cloudy urine
- difficult, burning, or painful urination
- frequent urge to urinate
- lower back or side pain
Other side effects of Zoryve Foam
Some side effects of roflumilast topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common side effects
For healthcare professionals
Applies to roflumilast topical: topical cream, topical foam.
General adverse events
The most common side effect that led to discontinuation was application site urticaria.[Ref]
Gastrointestinal
- Common (1% to 10%): Diarrhea, nausea[Ref]
Local
- Common (1% to 10%): Application site pain[Ref]
Nervous system
- Common (1% to 10%): Headache[Ref]
Psychiatric
Respiratory
- Common (1% to 10%): Upper respiratory tract infection[Ref]
Genitourinary
- Common (1% to 10%): Urinary tract infection[Ref]
See also:
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Dexamethasone
Dexamethasone is used to treat inflammatory conditions such as allergies, skin conditions ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Deltasone
Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Zoryve
Zoryve cream is used to treat plaque psoriasis and atopic dermatitis, and Zoryve foam is used for ...
Nizoral Topical
Nizoral Topical is used for cutaneous candidiasis, dandruff, seborrheic dermatitis, tinea corporis ...
Selsun Blue
Selsun Blue is used for dandruff, seborrheic dermatitis, tinea versicolor
Selenium sulfide topical
Selenium sulfide topical is used for dandruff, seborrheic dermatitis, tinea versicolor
References
1. (2022) "Product Information. Zoryve (roflumilast topical)." Arcutis Biotherapeutics, Inc, 1
More about Zoryve Foam (roflumilast topical)
- Check interactions
- Compare alternatives
- Reviews (1)
- Dosage information
- During pregnancy
- Drug class: selective phosphodiesterase-4 inhibitors
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Zoryve Foam side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.